Antoni Bayés-Genís

Antoni Bayés-Genís

Head of the Cardiology Department

FESC MD PhD

Hospital Germans Trias i Pujol, Barcelona, ES

  • Radcliffe
  • OrcidID

Biography

Antoni Bayés-Genís is Head of the Heart Institute at the University Hospital Germans Trias i Pujol in Barcelona, and Professor of Cardiology at the Universitat Autònoma de Barcelona in Barcelona, Spain.

Prof Bayés-Genís is an expert on biomarker, including natriuretic peptides ST2 and neprilysin, having lectured on the subject at numerous international meetings and generated research data that were later included in clinical guidelines.

His research is focused in two main areas, one more clinical and another basic-translational. From the clinical standpoint, he is interested in precision medicine in heart failure, biomarkers, sudden death, devices, new treatment options and epidemiology. At the basic-translational level, he focuses on novel regenerative approaches to rejuvenate the heart, including tissue engineering and cell-derived products.

Prof Bayés-Genís is past President of the Catalan Society of Cardiology, past Editor of Revista Española de Cardiología, and a member of the Royal Academy of Medicine of Catalonia. He has published over 620 articles with more than 20,000 citations. 

Dr Antoni Bayés-Genís is on the Editorial Board of European Cardiology Review.

Read more

Media

Antoni Bayés-Genís, Lisa Anderson, Stephen J Greene et al

Watch time: 44s (6 videos)

Giuseppe Rosano, Lisa Anderson, Antoni Bayés-Genís et al

Giuseppe Rosano, Lisa Anderson, Antoni Bayés-Genís, et al

Watch time: 41m 52s

John JV McMurray, Yuhui Zhang, Giuseppe Rosano, et al

Watch time: 17h 35m (23 videos)

Antoni Bayés-Genís, Julio Núñez

Watch time: 27m 19s (3 videos)

Articles by Antoni Bayés-Genís, Head of the Cardiology Department

Biomarkers to Improve Decision-making in Acute Heart Failure

Rafael de la Espriella, Gonzalo Núñez-Marín, Pau Codina, et al

Published:

Citation: Cardiac Failure Review 2023;9:e13.

DOI:

https://doi.org/10.15420/cfr.2023.08
The DELIVER Trial: the Beginning of the End of Ejection Fraction Tyranny

Antoni Bayés-Genís,

Published:

Citation: European Cardiology Review 2022;17:e30.

DOI:

https://doi.org/10.15420/ecr.2022.44
Biomarkers in Heart Failure with Preserved Ejection Fraction

Antoni Bayés-Genís, Germán Cediel, Mar Domingo, et al

Published:

Citation: Cardiac Failure Review 2022;8:e20.

DOI:

https://doi.org/10.15420/cfr.2021.37
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond

Alberto Aimo, Giosafat Spitaleri, Dario Nieri, et al

Published:

Citation: Cardiac Failure Review 2022;8:e12.

DOI:

https://doi.org/10.15420/cfr.2021.30
Heart Failure Treatment by Device

Antoni Bayés-Genís,

Published:

Citation: European Cardiology Review 2020;15:e17.

DOI:

https://doi.org/10.15420/ecr.2020.03
Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right

Antoni Bayés-Genís, Christian Muñoz-Guijosa, Evelyn Santiago-Vacas, et al

Published:

Citation: European Cardiology Review 2020;15:e19.

DOI:

https://doi.org/10.15420/ecr.2019.29.2
Left Ventricular Ejection Fraction in Heart Failure

Josep Lupón, Antoni Bayés-Genís,

Citation: European Cardiology Review 2018;13(2):91–2.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.GE1
Highlights Of The 2016 European Society Of Cardiology Guidelines On Heart Failure

Antoni Bayés-Genís,

Citation: European Cardiology Review 2017;12(2):76–7

DOI:

https://doi.org/10.15420/ecr.2017:5:2

Keywords

Cell Culture, Heart Failure, Genetic Engineering, Chronic Heart Failure, Cardiology, Electrocardiography, Acute Heart Failure, Cardiovascular, Heart, Cardiovascular System, Heart Rate Variability, Acute Coronary Syndrome, ECG, Cardiac Regeneration